State Regulators Step Up as Federal Oversight Weakens in Financial and Tech Sectors

As the Trump administration advances its deregulation agenda, state-level regulators—particularly in Democratic-led states—are increasing enforcement efforts to fill the void left by weakened federal oversight. This shift is evident across financial services, consumer protection, and emerging sectors like state-licensed medical marijuana, where states are asserting greater authority to protect residents and maintain market integrity.

Financial Regulation: States Respond to CFPB Rollbacks

With the Consumer Financial Protection Bureau (CFPB) experiencing significant staff reductions and diminished enforcement under the Trump administration, state attorneys general have stepped up actions against financial firms. In August 2025, New York Attorney General Letitia James announced a lawsuit against Early Warning Services, the operator of the Zelle payment network, alleging the company failed to prevent widespread fraud that cost consumers hundreds of millions of dollars. The suit mirrored a case previously filed by the CFPB, which was withdrawn in March 2025 as federal regulators scaled back their activities.

This pattern reflects a broader trend: state regulators are not only enforcing existing state and federal laws but also amending state legislation to expand their authority. States like New York, Massachusetts, and Maryland have ramped up regulatory activity, leveraging the redundancy in the U.S. Regulatory system to maintain oversight when federal agencies retreat.

Securities and Consumer Protection: Coordinated State Action

In the first three months of the second Trump administration, federal regulators signaled a shift in priorities, effectively shuttering the CFPB and restructuring the Securities and Exchange Commission’s (SEC) enforcement procedures. In response, state attorneys general have increased coordination, sharing information and aligning enforcement efforts to ensure consistency across jurisdictions.

State officials are using tools such as enforcing consumer financial protection laws, pursuing securities violations, and updating state statutes to enhance their regulatory reach. This coordinated approach aims to prevent a patchwork enforcement landscape from creating loopholes that could be exploited by financial institutions.

Medical Marijuana: Federal Deference to State Programs

In a notable development in April 2026, the U.S. Department of Justice announced it would ease federal restrictions on state-licensed medical marijuana by reclassifying it from Schedule I to Schedule III under the Controlled Substances Act. The move, signed by Acting Attorney General Todd Blanche, acknowledges the medical use of marijuana and reduces barriers to research, while maintaining federal oversight over recreational use.

The decision follows an executive action by President Trump and reflects a growing federal willingness to defer to state-regulated medical marijuana programs. State-licensed operators now face fewer federal restrictions, though the DEA plans to hold an administrative hearing on June 29, 2026, to consider broader reclassification efforts.

Implications for Businesses and Consumers

The evolving regulatory landscape creates both challenges and opportunities. Financial and tech companies operating nationally must now navigate a more fragmented compliance environment, where requirements can vary significantly from state to state. However, the increased state activity also enhances consumer protections in areas where federal oversight has waned.

Experts note that the redundancy in the U.S. Regulatory system—often criticized for inefficiency—has become a strength in times of federal retreat. As one analyst observed, “when one regulator is neutered, another can step in.” This dynamic is likely to continue shaping policy in financial technology, consumer finance, and emerging industries as long as federal priorities remain in flux.

Key Takeaways

• State attorneys general are increasing enforcement in financial services as federal regulators scale back the CFPB.
• New York’s lawsuit against Zelle reflects a broader trend of states stepping in when federal actions are withdrawn.
• State regulators are coordinating more closely to ensure consistent enforcement across jurisdictions.
• The DOJ’s 2026 decision to reclassify state-licensed medical marijuana to Schedule III signals federal deference to state programs.
• Businesses must adapt to a patchwork regulatory environment, while consumers benefit from sustained oversight at the state level.